• Users Online: 55
  • Print this page
  • Email this page
Year : 2021  |  Volume : 11  |  Issue : 1  |  Page : 1-4

The relevance of bare-metal stent in the therapy of coronary artery disease in 2020

Department of Cardiology, Vivekananda Institute of Medical Sciences, Kolkata, West Bengal, India

Correspondence Address:
Dr. Saumitra Ray
99/5/C, Ballygunge Place, Kolkata - 700 019, West Bengal
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/JICC.JICC_30_20

Rights and Permissions

First percutaneous transluminal coronary angioplasty (PTCA) using an expandable balloon was performed by Andreas Gruentzig in 1977. Since then, the process has seen exponential development. Stent deployment was the most important milestone in this journey. An original stent made of metals or metal alloys was called a bare-metal stent (BMS). They ruled the roost for more than a decade when stents coated with antiproliferative drug impregnated polymers, called drug-eluting stent came and became the tool of choice in almost all clinical scenarios of PTCA. However, still today, BMS has got a small but significant place in the cardiac catheter laboratory. The relevance of BMS in the therapy of coronary artery disease in today's world is reviewed in this article.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded55    
    Comments [Add]    

Recommend this journal